VivoSim Labs to Showcase Breakthrough Multiparametric

New Post Public Reply Private Reply Replies (0) Message Board
louied91
68
VivoSim Labs to Showcase Breakthrough Multiparametric NAMkind™ Liver and Intestine Data at the 2026 American College of Toxicology (ACT) Annual Meeting

https://www.globenewswire.com/news-release/20...eting.html  

New data on 10 compounds pulled due to unforeseen liver tox highlight how VivoSim’s models often easily catch clinical failure risk missed by animal models, using a complex approach that leverages several parameters studied simultaneously

SAN DIEGO, Nov. 16, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc., (Nasdaq: VIVS) (the “Company” or “VivoSim”), a leader and pioneer in next generation human-relevant New Approach Methodologies (NAMs) 3d human cellular models for preclinical safety and translational efficacy, announced today that its scientific team is presenting two landmark studies at the 2026 American College of Toxicology (ACT) Annual Meeting, taking place November 15–18 in San Antonio, Texas.

The presentations underscore the transformative power of VivoSim’s multiparametric approach across its proprietary NAMkind™ Liver and NAMkind™ Intestine platforms. Instead of measuring solely cell death, VivoSim sets a new standard by integrating multiple complementary endpoints with extended repeat-dose experimentation.

VivoSim’s models successfully characterized complex mechanisms of drug-induced liver injury (DILI) and gastrointestinal toxicity, including compounds discontinued in clinical development and advanced modalities such as antibody-drug conjugates (ADCs) and CDK inhibitors.

Previously, VivoSim provided data from older, classic liver toxicity benchmark compounds, but in San Antonio the company is presenting data on 10 newly tested compounds. Each of these compounds was a drug candidate that passed its nonclinical safety package, including conventional animal studies—the standard, commonly used route to first-in-human trials. These compounds were therefore cleared to enter human trials, where liver safety signals later emerged and development was halted in mid- to late-stage clinical trials. Conventional preclinical methods missed these liabilities, yet VivoSim’s 3D human model and multiparametric methodology in this experiment clearly flag all 10. This work demonstrates the immediate, real-world value of our platform in preventing costly clinical attrition today. Used ahead of first-in-human studies, testing in NAMkind™ Liver can flag liver liabilities while there is still time to redesign or drop a candidate, and help reduce costly liver-related clinical failures.

Multiparametric Resolution of Clinical Attrition in Liver Spheroids

In the first study (Poster #P419: NAMkind™ Liver Multiparametric Analysis Detects Liver Injury Signals in Drug Candidates Discontinued During Early Clinical Development), VivoSim evaluated 10 clinical drug candidates that successfully cleared conventional nonclinical animal safety studies but were later discontinued due to human hepatotoxicity.

Using the 3D human primary liver spheroid platform under 17-day repeated dosing, researchers tracked four complementary endpoints: ATP (metabolic/mitochondrial stress), albumin (hepatocyte function), total glutathione (GSH; oxidative stress), and lactate dehydrogenase (LDH; membrane lysis).

Cmax-normalized margin of safety (MOS) radar profiles successfully identified injury-related signals across all 10 discontinued candidates, spanning metabolic/lipid handling, aldehyde oxidase biotransformation, mitochondrial disruption, and undefined mechanisms.

"Traditional single-endpoint assays and animal models frequently fail to capture delayed or human-specific metabolic liabilities," said Dr. Amar A. Sethi, Chief Scientific Officer at VivoSim Labs. "By applying a rigorous multiparametric approach in NAMkind™ Liver, we are able to look beyond basic cell viability and map out the exact convergence of various tissue stresses (functional, oxidative, and metabolic). This gives sponsors actionable mechanistic insight into liver toxicity risk margins long before clinical trials begin."

Decoding Regional and Culture-State Intestinal Vulnerabilities

In the second study (Poster #P421: NAMkind™ Intestine Profiles Region- and Culture-State-Dependent Epithelial Liabilities of CDK Inhibitors and Tubulin Inhibitor-Linked ADCs), VivoSim demonstrated how polarized human colon and ileum models in both proliferative and differentiated states capture complex gastrointestinal toxicities.

Evaluating five cyclin-dependent kinase (CDK) inhibitors and deruxtecan and vedotin-linked ADCs across transepithelial electrical resistance (TEER), Alamar Blue (metabolic competence), and CTG ATP (viability), the study revealed:

Despite sharing cell-cycle pharmacology, CDK inhibitors exhibited highly diverse regional and endpoint-specific MOS profiles that mirrored clinical diarrhea incidence and severity.
Proliferative cultures demonstrated heightened barrier susceptibility (TEER), whereas differentiated cultures highlighted distinct metabolic-competence sensitivities, proving that epithelial cellular state profoundly influences toxicity manifestation.
Histological and functional readouts confirmed concentration-dependent architectural disruption and severe barrier breakdown caused by vedotin payloads in differentiated colon epithelium.

"Gastrointestinal toxicity is a major hurdle in oncology and targeted therapeutics, yet conventional systems struggle to differentiate regional and cellular-state sensitivities," noted Keith Murphy, Executive Chairman at VivoSim Labs. "Our latest intestinal data show that NAMKind Intestine regional tissue architecture with multiparametric readouts provides close correlation with known clinical outcomes. This system provides biopharma developers with an unprecedented lens to evaluate epithelial barrier integrity, optimize lead candidates, and align with modern regulatory frameworks like the FDA Modernization Act 2.0."

Presentation Details

Poster #P419 (Liver): NAMkind™ Liver Multiparametric Analysis Detects Liver Injury Signals in Drug Candidates Discontinued During Early Clinical Development
Poster #P421 (Intestine): NAMkind™ Intestine Profiles Region- and Culture-State-Dependent Epithelial Liabilities of CDK Inhibitors and Tubulin Inhibitor-Linked ADCs
Conference: American College of Toxicology (ACT) Annual Meeting, San Antonio, TX
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dolby's Strong Quarter Meets a Flat 2027 Reality Check

Updated Category News Views 67

A licensing machine just coughed up a very good quarter, then told investors not to expect the engine to accelerate next year. That is the whole Dolby story in one uncomfortable breath. NYSE:DLB finished fiscal 2026 with fourth-quarter revenue of $374 million, up from $307 million a year earlier, while GAAP diluted earnings climbed to $0.86 from $0.51. Those are not...

Continue Reading
Abacus Global Faces Scrutiny Over Accounting Practices

Updated Category News Views 176

Storm Clouds Gather over Abacus Global Management If it ain't one thing, it's another—at least that's what folks holding the bag with Abacus Global (ABX) are thinking right now. News of a pending investigation has dropped like a lead balloon, and the air is thick with scrutiny over their financial dealings. We're jawing about related-party transactions now under the...

Continue Reading
Azazie Tests Bridal Demand With Two East Coast Pop-Ups

Updated Category News Views 116

Wedding dresses are a miserable product to buy sight unseen, no matter how pretty the product photos look. That basic fact is why Azazie’s two East Coast pop-ups on November 21 and 22 deserve a closer look. This is not some grand retail rollout, and nobody should pretend a pair of short events rewrites the bridal market. But it is a practical test of where a...

Continue Reading
Linux Foundation Unveils the Global Fraud Alliance

Updated Category News Views 99

Who would have thought the tech wizards at the Linux Foundation would step up to tackle fraud on a global scale? That's what we've got with their latest play: the Open Financial Trust Alliance (OFTA). Launched at the Singapore FinTech Festival, they've got their sights on connecting the world's disconnected fraud fight. Think of it as a translator for the tangled mess of...

Continue Reading
MAXHUB's Canon Office Test Puts Hybrid Work on Trial

Updated Category News Views 81

Thirty-nine devices scattered through a new Hong Kong office may not sound earth-shaking, but this is how workplace technology actually earns its keep: not under trade-show lights, but when somebody is late to a meeting in another time zone and the room has to work anyway. MAXHUB and Canon Hong Kong have launched the first officially delivered Co-Create 100 project...

Continue Reading
ISDN Holdings: Leading APAC Automation with Innovation

Updated Category News Views 81

Pioneering Automation Intelligence in APAC Not every day you hear a company quietly revolutionizing an entire industry's landscape—but ISDN Holdings Limited is one of those rare players. Recognized by Frost & Sullivan for its top-tier customer value leadership, ISDN is making waves across the Asia-Pacific's industrial scene with its integrated industrial automation...

Continue Reading
Spruce Spins Adrenyx En Route to Nasdaq in 2027

Updated Category News Views 143

New Frontiers: Adrenyx Biosciences Takes Shape Well, here's a new chapter in biotech drama. Spruce Biosciences, a name you might have tangled with if you're into tickers like NASDAQ:SPRB, just carved out a niche with the birth of Adrenyx Biosciences. The play? A separate company eyeing the endocrinology space, setting its sights on tackling congenital adrenal hyperplasia...

Continue Reading
Chaos Zero Nightmare's Award Is a Useful Signal for Games

Updated Category News Views 189

A story award can be easy to sneer at until a live-service game earns one across three markets. Smilegate's Chaos Zero Nightmare, a dark fantasy roguelike RPG developed by Super Creative, was named Best Story in Google Play's Best of 2026 awards for Taiwan, Hong Kong and Macau. That is not a sales figure, not a profit disclosure, and certainly not proof that a hit has...

Continue Reading
Avelo Tests Loyalty Math With WeSalute Fare Discounts

Updated Category News Views 277

Airline discounts can look like generosity until the load factor starts talking back. Avelo Airlines has joined WeSalute with fare discounts for active-duty military members, veterans, first responders, nurses, medical professionals, public servants, teachers and eligible family members. It is a sensible move for a young carrier built around smaller airports and lower...

Continue Reading
VeriSilicon's New AI/AR Glasses Tech: Game-Changer?

Updated Category News Views 159

VeriSilicon Unveils Next-Generation Subsystem There's some sizzle in the air with VeriSilicon's latest move in the wearable tech arena. They’ve launched a low-power, high-performance subsystem aimed squarely at AI and augmented reality glasses. Now, these gizmos aren't just the stuff of science fiction. Thanks to their Nano-XR series, reality might just get a splash...

Continue Reading

Top 5 Most Recently Viewed Articles

S&P CoreLogic Case-Shiller Index Highlights Growth Trends

Updated Category News Views 141

Overview of the Recent S&P CoreLogic Case-Shiller Index S&P Dow Jones Indices has released the results from its well-regarded S&P CoreLogic Case-Shiller Indices, revealing insightful trends in the U.S. housing market. The data indicates a notable 3.9% annual gain for December, reflecting a slight increase from previous figures earlier in the year. With over 27 years of...

Continue Reading
Baader Bank Enhances OTC Trading with New Extended Hours

Updated Category News Views 95

Baader Bank Expands OTC Trading Hours MUNICH - Baader Bank AG, a prominent player in the German financial services sector, has recently announced a significant enhancement to its over-the-counter (OTC) trading hours. Starting today, clients can now engage in trading activities from 07:30 to 23:00. This extension is part of the bank's strategic initiative to bolster its...

Continue Reading
Nokia Strengthens Alliance with SoftBank Through Network Upgrade

Updated Category News Views 644

Nokia Strengthens Alliance with SoftBank Through Network Upgrade Nokia has taken significant strides in enhancing its partnership with SoftBank Corp. through a new agreement focused on the modernization of network systems in Japan. This expansion involves the deployment of innovative 4G and 5G radio access solutions underpinned by Nokia's advanced AirScale portfolio....

Continue Reading
IS4S Launches Office to Enhance Regional Defense Solutions

Updated Category News Views 251

IS4S Expands Operations with New Office Launch Integrated Solutions for Systems, Inc. (IS4S) has proudly announced the opening of its latest office, strategically situated to support its operations in New England. This new location enhances IS4S's capacity to engage with stakeholders associated with various Air Force programs, especially those managed by the Air Force...

Continue Reading
Discover the Future of Contract Management with CobbleStone

Updated Category News Views 141

CobbleStone Software to Showcase Contract Management Solutions CobbleStone Software is set to exhibit its cutting-edge, AI-enhanced contract management solutions at an upcoming event, bringing together legal professionals from various sectors. This performance is part of the anticipated 2025 ACC Annual Meeting, where the company will engage with leaders in the legal...

Continue Reading